Related Experiment Video
Updated: Aug 11, 2026
A 3D System for Culturing Human Articular Chondrocytes in Synovial Fluid
Published on: January 31, 2012
Enhancing GFPT1 expression with glutamine protects chondrocytes in osteoarthritis
Zhao Zhang1, Xinyu Li1, Weihua Guo2
1Department of Orthopaedic Surgery, Orthopaedic Research Institute, West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan Province, People's Republic of China.
Objective:
Osteoarthritis (OA) is the leading joint disease without currently available disease-modified drugs. The current study aimed to identify potential drug targets that could decelerate the progression of OA.
Methods:
We employed Mendelian Randomization (MR) and colocalization analysis to identify therapeutic targets linked to 12 OA traits within 2645 targets. Bulk and single-cell RNA-seq analyses of cartilage samples were conducted to pinpoint GFPT1 and determine the specific cell types in which GFPT1 is expressed. Overexpression and knockdown experiments further explored the expression and potential OA-associated functions of GFPT1.
Results:
GFPT1 has been identified as a cross-OA therapeutic candidate gene by MR analysis. We observed a significant reduction in GFPT1 expression in OA cartilage compared to normal cartilage from public transcriptomic data of both humans and mice. In vitro experiments confirmed these findings at both mRNA and protein levels in OA chondrocytes. IL-1β stimulation leads to downregulation of GFPT1. We confirmed that supplementary glutamine can reverse the suppression of GFPT1 more effectively than glucosamine in the OA in vitro model. GFPT1 upregulation with glutamine, in turn, further increases the expression of COL2A1 and decreases the expression of MMP13.
Conclusions:
Our findings demonstrate that GFPT1 is downregulated in OA, and overexpressing GFPT1 can restore the anabolic metabolism of cartilage. Compared to glucosamine, enhancing GFPT1 expression with glutamine to influence the hexosamine biosynthetic pathway may offer a more effective therapeutic strategy for OA.
Insights
Glutamine supplementation may offer a novel therapeutic strategy for osteoarthritis (OA) by upregulating GFPT1 expression, restoring cartilage anabolic metabolism. This approach shows promise in decelerating OA progression.
Area of Science:
- Biochemistry
- Genetics
- Pharmacology
Background:
- Osteoarthritis (OA) is a prevalent degenerative joint disease with no disease-modifying drugs.
- Current treatments primarily manage symptoms, highlighting the need for novel therapeutic targets to slow OA progression.
Purpose of the Study:
- To identify potential drug targets for decelerating osteoarthritis progression.
- To investigate the role of GFPT1 in OA pathogenesis and its potential as a therapeutic target.
Main Methods:
- Mendelian Randomization (MR) and colocalization analysis were used to identify therapeutic targets linked to OA traits.
- Bulk and single-cell RNA sequencing analyzed cartilage samples to pinpoint GFPT1 expression.
- In vitro experiments (overexpression, knockdown) assessed GFPT1 function in OA chondrocytes.
Main Results:
- GFPT1 was identified as a cross-OA therapeutic candidate gene.
- GFPT1 expression was significantly reduced in OA cartilage from human and mouse samples.
- Glutamine supplementation reversed GFPT1 suppression more effectively than glucosamine, restoring COL2A1 and decreasing MMP13 expression.
Conclusions:
- GFPT1 is downregulated in OA, and its upregulation can restore cartilage anabolic metabolism.
- Enhancing GFPT1 expression via glutamine, targeting the hexosamine biosynthetic pathway, presents a promising therapeutic strategy for OA.
